Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00726193 · ClinicalTrials.gov registry record
Study to Analyze the Effects of EBI OsteoGen™ on the Surgical Reconstruction of Tibia Non-unions
A clinical trial, sponsored by Zimmer Biomet.
- Terminated
- Registry status
- 4
- Enrollment target
NCT00726193: Clinical Trial study, sponsored by Zimmer Biomet.
NCT00726193 is a clinical trial that was terminated before completion, run by Zimmer Biomet. The registered enrollment target is 4 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00726193 was terminated before completion, sponsored by Zimmer Biomet.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The purpose of this clinical outcomes collection study is to analyze the effect of the EBI OsteoGen™ Direct Current Stimulator upon surgical reconstruction of tibia nonunion (no visible progressive signs of healing) fracture in a prospective database.
Interventions
- DEVICE OsteoGen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2006-06 |
| Est. Completion | 2008-04 |
Why NCT00726193 stopped before completion
NCT00726193 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 4 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which OsteoGen is the first listed.
NCT00726193 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00726193 about?
NCT00726193 is a clinical study titled "Study to Analyze the Effects of EBI OsteoGen™ on the Surgical Reconstruction of Tibia Non-unions". The purpose of this clinical outcomes collection study is to analyze the effect of the EBI OsteoGen™ Direct Current Stimulator upon surgical reconstruction of tibia nonunion (no visible progressive signs of healing) fracture in a prospective database.
What is the current status of trial NCT00726193?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2006-06. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00726193?
The interventions under investigation include: OsteoGen (DEVICE).
Who is sponsoring clinical trial NCT00726193?
This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia